W1M Asset Management Ltd lessened its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report) by 98.3% during the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 15,282 shares of the company’s stock after selling 910,002 shares during the quarter. W1M Asset Management Ltd’s holdings in GE HealthCare Technologies were worth $978,000 at the end of the most recent quarter.
Other hedge funds have also recently bought and sold shares of the company. Laurel Wealth Advisors LLC purchased a new position in GE HealthCare Technologies during the 4th quarter valued at about $26,000. Godfrey Financial Associates Inc. acquired a new position in GE HealthCare Technologies in the 4th quarter valued at about $27,000. Montag A & Associates Inc. increased its stake in GE HealthCare Technologies by 105.4% during the fourth quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock worth $28,000 after purchasing an additional 175 shares during the period. Transamerica Financial Advisors LLC increased its stake in GE HealthCare Technologies by 331.6% during the fourth quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock worth $28,000 after purchasing an additional 262 shares during the period. Finally, MV Capital Management Inc. acquired a new stake in shares of GE HealthCare Technologies during the fourth quarter worth about $33,000. Institutional investors and hedge funds own 82.06% of the company’s stock.
Wall Street Analyst Weigh In
GEHC has been the subject of several recent research reports. Piper Sandler reissued a “buy” rating on shares of GE HealthCare Technologies in a research note on Wednesday, July 29th. BMO Capital Markets started coverage on shares of GE HealthCare Technologies in a research note on Wednesday, July 8th. They set a “market perform” rating and a $70.00 target price on the stock. HSBC reduced their target price on shares of GE HealthCare Technologies from $100.00 to $90.00 in a report on Thursday, April 30th. Citigroup raised their price target on shares of GE HealthCare Technologies from $69.00 to $75.00 and gave the company a “neutral” rating in a research report on Thursday, July 30th. Finally, Evercore restated an “outperform” rating and issued a $84.00 price target on shares of GE HealthCare Technologies in a research note on Thursday, July 30th. Ten equities research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, GE HealthCare Technologies presently has a consensus rating of “Hold” and a consensus price target of $77.73.
GE HealthCare Technologies Stock Performance
Shares of GE HealthCare Technologies stock opened at $74.82 on Friday. GE HealthCare Technologies Inc. has a one year low of $58.75 and a one year high of $89.77. The company has a market cap of $33.80 billion, a PE ratio of 17.16, a P/E/G ratio of 2.16 and a beta of 0.69. The company has a debt-to-equity ratio of 0.92, a quick ratio of 0.97 and a current ratio of 1.26. The business has a 50-day simple moving average of $66.61 and a 200-day simple moving average of $69.60.
GE HealthCare Technologies (NASDAQ:GEHC – Get Free Report) last released its earnings results on Wednesday, July 29th. The company reported $1.13 earnings per share for the quarter, topping analysts’ consensus estimates of $1.04 by $0.09. The firm had revenue of $5.29 billion for the quarter, compared to analyst estimates of $5.26 billion. GE HealthCare Technologies had a net margin of 9.33% and a return on equity of 20.12%. The business’s quarterly revenue was up 5.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.06 earnings per share. On average, equities research analysts forecast that GE HealthCare Technologies Inc. will post 4.93 EPS for the current fiscal year.
GE HealthCare Technologies Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Friday, August 14th. Shareholders of record on Friday, July 24th were given a $0.035 dividend. The ex-dividend date of this dividend was Friday, July 24th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is currently 3.21%.
About GE HealthCare Technologies
GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.
In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.
Further Reading
- Five stocks we like better than GE HealthCare Technologies
- 2 Biotech Stocks Shaping Up for Major Breakouts
- 3 Stocks Came Roaring Back—Now They’re Flashing Warning Signs
- 3 Beaten-Down Stocks That Haven’t Gotten the Message About the S&P 500’s Record Run
- Darden Restaurants Just Hit a 52-Week High–Is the Olive Garden Comeback Story Legit?
Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC – Free Report).
Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
